Skip to main content
Clinical Trials/NCT06201364
NCT06201364
Not yet recruiting
Phase 3

External Oblique Intercostal Block Versus Paravertebral Block for Postoperative Analgesia in Laparoscopic Cholecystectomy Patients

Assiut University0 sites80 target enrollmentFebruary 1, 2024
ConditionsAnesthesia

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Anesthesia
Sponsor
Assiut University
Enrollment
80
Primary Endpoint
total morphine consumption
Status
Not yet recruiting
Last Updated
2 years ago

Overview

Brief Summary

To compare external oblique intercostal block versus paravertebral block for post operative analgesia in patients undergoing laparoscopic cholecystectomy to decease post operative opioid consumption and use the least dose of local anesthesia.

Detailed Description

Paravertebral Block (PVB) involve injection of local anesthetic in a space immediately lateral to where the spinal nerves emerge from the intervertebral foramina. This technique is being used increasingly for not only intra-operative and post-operative analgesia but also as a sole anesthetic technique for carrying out various procedures. This popularity is mainly due to the ease of the technique and fewer complications. The external oblique intercostal block is a novel motor- and opioid-sparing technique which blocks both the anterior and lateral cutaneous branches of the thoracoabdominal nerves which innervate the upper abdominal quadrant.

Registry
clinicaltrials.gov
Start Date
February 1, 2024
End Date
August 1, 2025
Last Updated
2 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Mohamed Adel Abdelkareem

Doctor

Assiut University

Eligibility Criteria

Inclusion Criteria

  • Patients between 20-60 years old
  • Patients with ASA clinical status I\\II
  • Patients schedule for laparoscopic cholecystectomy

Exclusion Criteria

  • Patients refusal
  • Coagulopathy
  • Infection at site of injection
  • Allergy of local anesthesia
  • Sever cardiac disease
  • Patients with chest wall deformities

Outcomes

Primary Outcomes

total morphine consumption

Time Frame: first 24 hours postoperatively

Secondary Outcomes

  • Time of first rescue analgesia(hours)
  • Visual analogue scale (VAS)(at 0.5 ,1,2,4,8,12,24 hours postoperatively)

Similar Trials